Liver Elastography with Controlled Attenuation Parameter: Clinical Trials

1 trial of Liver Elastography with Controlled Attenuation Parameter, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 not yet recruiting. .

Follow Liver Elastography with Controlled Attenuation Parameter: new trials by email Literature Review of Liver Elastography with Controlled Attenuation Parameter trials Research Report on Liver Elastography with Controlled Attenuation Parameter

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Biomarker Panel for PCOS-Associated Liver Steatosis in Adolescent Girls (COMPASS-pedPCOS)
Extended Serum Biomarker and Hormonal Panel, Liver Elastography with Controlled Attenuation Parameter, Targeted Genotyping of PNPLA3 rs738409 and HSD17B13 rs72613567 - Polycystic Ovary Syndrome (PCOS), Metabolic Dysfunction-Associated Steatotic Liver Disease
Not yet recruitingKayseri City Hospital1502026-09-012026-07-30

Conditions studied

Fatty Liver (1)  ·  Hyperandrogenism (1)  ·  Metabolic Syndrome (1)  ·  Pediatric Obesity (1)  ·  Polycystic Ovary Syndrome (1)

Sponsors

Kayseri City Hospital (1)

Countries

Turkey (Türkiye) (1)

Results publications

PMID 18064739, PMID 18820647, PMID 18852641, PMID 26511519, PMID 27901631, PMID 29562163, PMID 31381969, PMID 37364790, PMID 37580861, PMID 40069730, PMID 8970487